A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-56136379 in Healthy Japanese Adult Participants
Clinical trial NCT02933580 · COMPLETED
Trial details
- NCT number
- NCT02933580
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-12
- Primary completion
- 2017-02-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.